Once the mechanistic role of VISTA in PCa is more fully understood, dual targeting with VISTA/CTLA-4 or VISTA/PD-1 bsAb may also prove beneficial in the clinic. The gene discussed is PDCD1; the disease is posterior cortical atrophy.